Article
High inherited risk predicts age-associated increases in fibrosis in patients with MASLD.
Journal of hepatology - 1 Oct 2025
Díaz Luis Antonio, Alazawi William, Agrawal Saaket, Arab Juan Pablo, Arrese Marco, Idalsoaga Francisco, Barreyro Fernando Javier, Gadano Adrian, Marciano Sebastián, Martínez Morales Jorge, Villela-Nogueira Cristiane, Leite Nathalie, Couto Claudia Alves, Theodoro Rafael, Monteiro Mísia Joyner de Sousa Dias, Oliveira Claudia P, Pessoa Mario G, Alvares-da-Silva Mario Reis, Madamba Egbert, Bettencourt Ricki, Richards Lisa M, Majithia Amit R, Khera Amit V, Loomba Rohit, Ajmera Veeral
Abstract excerpt
BACKGROUND & AIMS: Limited data have prevented routine genetic testing from being integrated into clinical practice in metabolic dysfunction-associated steatotic liver disease (MASLD). We aimed to quantify the effect of genetic variants on changes in fibrosis severity per decade in patients with MASLD. METHODS: This cross-sectional study included prospectively recruited adults with MASLD aged 18-70 who underwent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
